TFF Pharmaceuticals (TFFP) News Today → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free TFFP Stock Alerts $1.81 -0.14 (-7.18%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 1, 2024 | globenewswire.comTFF Pharmaceuticals Announces Closing of Pricing of $4.8 Million Public OfferingApril 29, 2024 | globenewswire.comTFF Pharmaceuticals Announces Pricing of $4.8 Million Public OfferingApril 29, 2024 | reuters.comTurkish federation investigates match-fixing allegations in third-tier gameApril 29, 2024 | globenewswire.comTFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual MeetingApril 17, 2024 | msn.comTFF Pharmaceuticals (TFFP) Price Target Decreased by 28.99% to 24.99April 15, 2024 | markets.businessinsider.comTFF Pharmaceuticals Reports Addl. Positive Phase 2 Data For Tacrolimus Inhalation PowderApril 15, 2024 | globenewswire.comTFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract SessionsApril 1, 2024 | finance.yahoo.comTFF Pharmaceuticals Full Year 2023 Earnings: Misses ExpectationsMarch 29, 2024 | investing.comTFF Pharmaceuticals reports positive phase 2 trial resultsMarch 29, 2024 | finanznachrichten.deTFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 28, 2024 | investorplace.comTFFP Stock Earnings: TFF Pharmaceuticals Beats EPS, Beats Revenue for Q4 2023March 28, 2024 | globenewswire.comTFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial ResultsMarch 27, 2024 | globenewswire.comTFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical ProgramsMarch 25, 2024 | globenewswire.comTFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 MeetingMarch 22, 2024 | globenewswire.comTFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesMarch 21, 2024 | finance.yahoo.comTFF Pharmaceuticals, Inc. (TFFP)March 20, 2024 | marketbeat.comTrading was temporarily halted for "TFFP" at 12:03 PM with a stated reason of "LULD pause."March 20, 2024 | globenewswire.comTFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesMarch 20, 2024 | globenewswire.comTFF Pharmaceuticals Announces Update on Clinical ProgramsMarch 14, 2024 | globenewswire.comTFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024March 12, 2024 | uk.investing.comTff Pharmaceuticals Inc (TFFP)February 29, 2024 | marketbeat.comTrading was temporarily halted for "TFFP" at 09:02 AM with a stated reason of "LULD pause."January 24, 2024 | finance.yahoo.comTFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis ConferenceJanuary 9, 2024 | finance.yahoo.comTFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 MeetingJanuary 5, 2024 | morningstar.comTFF Pharmaceuticals Inc Ordinary SharesDecember 21, 2023 | markets.businessinsider.comPositive Phase II Results Bolster Buy Rating for TFF Pharmaceuticals with Raised Price TargetDecember 19, 2023 | finanznachrichten.deTFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TACDecember 19, 2023 | markets.businessinsider.comTFF Pharma Reveals Positive Initial Data From Ongoing Phase 2 Trials Of TFF VORI And TFF TACDecember 19, 2023 | finance.yahoo.comTFF Pharmaceuticals Announces Positive Initial Data from Ongoing Phase 2 Trials of TFF VORI and TFF TACDecember 19, 2023 | marketbeat.comTrading was temporarily halted for "TFFP" at 07:12 PM with a stated reason of "News pending."December 18, 2023 | finance.yahoo.comTFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TACDecember 15, 2023 | markets.businessinsider.comTFF Declares Reverse Stock Split For 1 Post-split Share For Every 25 Pre-split SharesDecember 15, 2023 | finance.yahoo.comTFF Pharmaceuticals Announces Reverse Stock SplitNovember 30, 2023 | finance.yahoo.comTFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of DirectorsNovember 27, 2023 | finance.yahoo.comTFF Pharmaceuticals to Participate in the 2023 Benchmark Discovery One-on-One Investor Conference – December 7, 2023November 23, 2023 | morningstar.comTFF Pharmaceuticals Inc Ordinary Shares TFFPNovember 21, 2023 | msn.comTFF Pharmaceuticals files for $100M mixed shelfNovember 21, 2023 | markets.businessinsider.comBuy Rating Reaffirmed for TFF Pharmaceuticals: Promising Clinical Trials and Sufficient Funding ForecastedNovember 17, 2023 | finanznachrichten.deTFF Pharmaceuticals, Inc.: TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 16, 2023 | finance.yahoo.comTFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q3 2023 Earnings Call TranscriptNovember 14, 2023 | finance.yahoo.comTFF Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 8, 2023 | finance.yahoo.comTFF Pharmaceuticals Announces Publication of Data Demonstrating Feasibility of Intranasal Delivery of Monoclonal Antibodies with Thin Film FreezingNovember 7, 2023 | finance.yahoo.comTFF Pharmaceuticals to Hold Third Quarter 2023 Financial and Business Results Conference Call on November 14, 2023October 2, 2023 | finance.yahoo.comTFF Pharmaceuticals Congratulates our Scientific Advisory Board Member, Drew Weissman, M.D., Ph.D., for Receiving the Nobel Prize in Physiology or Medicine for his Pioneering Work Enabling the Development of mRNA COVID-19 VaccinesSeptember 28, 2023 | finance.yahoo.comTFF Pharmaceuticals to Participate in Upcoming Investor ConferencesAugust 23, 2023 | finance.yahoo.comTFF Pharmaceuticals to Participate in the H.C. Wainwright 25th Annual Global Investment Conference – September 11-13, 2023August 18, 2023 | benzinga.com10% Owner At This Health Care Company Sells $94K of StockAugust 18, 2023 | finance.yahoo.comCEO, Interim President & Vice Chairman of the Board of TFF Pharmaceuticals Picks Up 280% More StockAugust 17, 2023 | finance.yahoo.comTFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment OptionAugust 17, 2023 | finance.yahoo.comTFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q2 2023 Earnings Call Transcript Get TFF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter. Email Address America’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late. Click here to watch this bombshell exposé now. TFFP Media Mentions By Week TFFP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TFFP News Sentiment▼0.440.57▲Average Medical News Sentiment TFFP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TFFP Articles This Week▼21▲TFFP Articles Average Week Get TFF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sonnet BioTherapeutics News Today Protagenic Therapeutics News Today Ayala Pharmaceuticals News Today Cingulate News Today First Wave BioPharma News Today Hoth Therapeutics News Today Genprex News Today Xenetic Biosciences News Today Synaptogenix News Today Kintara Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TFFP) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe only AI company you should be looking atBehind the MarketsCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TFF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.